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Bone mesenchymal cells are central participants 
in hematopoiesis, providing niches regulating 
stem and progenitor cells. Lymphopoiesis de-
pends on tissues outside the bone marrow for 
terminal maturation, but antigen-independent 
specification of lymphoid lineages is hypothe-
sized to occur in bone marrow. B cell genera-
tion has been definitively shown to involve 
osteolineage cells, whereas T cell generation 
remains controversial (Visnjic et al., 2004; Zhu 
et al., 2007; Wu et al., 2008). Deletion of CXCL12 
in early osteolineage cells decreased B cell pro-
genitors, whereas deletion of osteocytes produced 
dramatic metabolic changes, primary damage 
to thymus, and decreased B and T cell generation 
through an undefined molecular mechanism 
(Ding and Morrison, 2013; Greenbaum et al., 
2013; Sato et al., 2013). Co-culture of hemato-
poietic progenitors with bone marrow stroma 
cells overexpressing Notch ligands enabled T cell 
lineage generation in vitro (Holmes and Zúñiga-
Pflücker, 2009), but whether this recapitulates 
in vivo events in the bone marrow microenvi-
ronment is unclear (Uhmann et al., 2011).
The details of the prethymic process are 
of increasing interest given that early thymic 
progenitors may serve as a limiting substrate in 
immune reconstitution after transplant (Zlotoff 
et al., 2011). It has been shown that providing 
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Production of the cells that ultimately populate the thymus to generate / T cells has 
been controversial, and their molecular drivers remain undefined. Here, we report that 
specific deletion of bone-producing osteocalcin (Ocn)-expressing cells in vivo markedly 
reduces T-competent progenitors and thymus-homing receptor expression among bone 
marrow hematopoietic cells. Decreased intrathymic T cell precursors and decreased genera-
tion of mature T cells occurred despite normal thymic function. The Notch ligand DLL4 is 
abundantly expressed on bone marrow Ocn+ cells, and selective depletion of DLL4 from 
these cells recapitulated the thymopoietic abnormality. These data indicate that specific 
mesenchymal cells in bone marrow provide key molecular drivers enforcing thymus-seeding 
progenitor generation and thereby directly link skeletal biology to the production of T cell–
based adaptive immunity.
© 2015 Yu et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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Welinder et al., 2011) and progenitors of other lineages, includ-
ing common myeloid progenitor (CMP), granulocyte and 
macrophage progenitor (GMP), and megakaryocyte erythroid 
progenitor (MEP), were not changed (Fig. 2 B). We observed a 
decrease in bone marrow pro–B subsets, but not in prepro–B 
cells or downstream pre–B and mature B cells (Fig. 2 D). Spleen 
weight, cellularity, and B cell count were also not signifi-
cantly affected. The decrease in B cell intermediates, whereas 
Ly6D+CLP were normal suggests that specification of B- 
lineage was not perturbed, but that support of downstream 
differentiation events was abnormal, as has been seen in other 
osteolineage modifications (Zhu et al., 2007; Wu et al., 2008; 
Ding and Morrison, 2013; Greenbaum et al., 2013).
Accompanying the decreased T-competent CLPs in the 
bone marrow, downstream T-progenitor and mature cells in the 
thymus were also reduced (Fig. 2 E). We confirmed that 
Ly6DCLP are T cell competent by transplantation (Fig. 3 A), 
and we examined populations others have used in defining 
T-competent CLP (Flt3+Ly6DCLP [Karsunky et al., 2008; 
Inlay et al., 2009] and CLP-1 [Scimone et al., 2006; Krueger 
and von Boehmer, 2007]). Decreases in each of these was 
seen with Ocn+ cell depletion and levels were comparable 
to Ly6DCLP (unpublished data). Of note, there was no de-
tectable DTR expressed on CLPs to suggest ectopic cell killing 
by DT.
Despite the increased immunophenotypic hematopoietic 
stem and progenitor cell (HSPC; LinSca+cKit+CD48CD150+) 
number, cell cycling (Fig. 3, B–D), and increased reconstitu-
tion at 8 and 12 wk after bone marrow transplantation (Fig. 3 E), 
no long-term advantage in reconstitution was scored at 16 wk 
after primary transplantation in a competitive transplant assay. 
There was also no detectable change in secondary transplan-
tation of cells from the Ocn+ deleted animals. These data 
are consistent with altered cycling of long-term HSC (LT 
HSC) without an effect on the functionally defined reconsti-
tuting ability of these cells by primary and secondary trans-
plantation. The data indicate an effect on short-term HSC (ST 
HSC) and do not exclude an effect on LT HSC, just not a 
change in their reconstituting ability from the Ocn+ cell de-
pleted bone marrow. It is possible that longer term exposure to 
the Ocn+ cell–depleted marrow would affect functional LT 
HSC number. It is also possible that other important functional 
changes were induced, but not measured in our studies.
To evaluate the microenvironment dependence of 
T-lymphopoiesis, WT congenic hematopoietic cells were 
transplanted into OcnCre+/;iDTR hosts; the abnormal lym-
phopoietic phenotype was recapitulated (Fig. 4 A). Recipro-
cally, OcnCre+/;iDTR mutant donor bone marrow reverted 
to normal phenotype when transplanted into WT congenic 
hosts (Fig. 4 B). Testing whether the effect was on the basis 
of differential cell proliferation or survival, CLP cell cycling 
by Ki67 and DAPI staining and cell death by Annexin V and 
7-amino-actinomycin D (7-AAD) staining were assessed and 
no significant differences were observed (Fig. 4 C), suggesting 
alternative mechanisms must be active.
ex vivo generated human pro–T cells improved T cell recon-
stitution, thymic architecture, and immunological competence 
in immunodeficient mice (Zakrzewski et al., 2006; Awong et al., 
2013). Therefore, understanding and modulating the produc-
tion of bone marrow–derived cells that can populate the thy-
mus may have practical consequences in medicine.
RESULTS
We generated mouse strains in which Cre recombinase pro-
duced by either the Osteocalcin promoter expressed in mature 
osteoblasts and osteocytes, or the Osterix promoter expressed 
in distinct, more immature subsets of bone cells, drives ex-
pression of the diphtheria toxin (DT) receptor (DTR) on cell 
surface (OcnCre+/;iDTR and OsxCre+/;iDTR, respec-
tively; OcnCre+/ and OsxCre+/ served as controls). Specific 
in vivo cell ablation was achieved by intraperitoneal injection 
of DT. Daily injections into both control and mutant animals 
began at age 4 wk, and by 6 wk a difference in body size was 
noted in both the OsxCre+/;iDTR and OcnCre+/;iDTR 
mutant mice compared with littermate controls, which is 
consistent with inhibition of bone formation (Fig. 1 A). In 
early experiments, OsxCre+/;iDTR and OcnCre+/;iDTR 
animals without DT treatment were assessed and no pheno-
typic difference with the OsxCre+/ and OcnCre+/ controls 
were noted and therefore are not presented further. The T lym-
phopenic effect was observed only in the OcnCre+/;iDTR 
strain and not the OsxCre+/;iDTR strain, and thus it is the 
focus of this work.
Histomorphometry revealed 70% deletion of osteo-
blasts and osteocytes in the OcnCre+/;iDTR mutants (Fig. 1, 
B and C). To evaluate whether DTR was expressed in the 
correct cells in bone marrow, immunohistochemistry for 
DTR without toxin injection was performed and demon-
strated overlap with anti-Ocn staining (Fig. 1 D). TUNEL 
staining after DT administration demonstrated overlap with 
osteocalcin-specific antibodies (Fig. 1 E), indicating selective 
cell killing.
Osteoclasts were assessed by TRAP staining and histomor-
phometry (Fig. 1 F), and measuring endogenous osteoclast 
activity (Fig. 1 G); these indices were not affected by 2 wk 
of toxin administration in OcnCre+/;iDTR mice. Testing 
whether osteolineage cell depletion might lead to an excess of 
primitive responding bone progenitor cells, primitive mesenchy-
mal progenitors were assessed by colony forming unit-osteoblast 
(CFU-Ob) assays and found to be unchanged (Fig. 1 H). No 
detectable changes in CD31CD45Ter119LepR+ stromal 
cells were observed (Fig. 1 I).
Despite the changes in bone morphology, overall bone 
marrow cellularity was unaffected as were blood and bone 
marrow counts of mature hematopoietic cells except lymphoid 
cells (Fig. 2 A). This was associated with reduced common 
lymphoid progenitors (CLPs) within the bone marrow and 
blood and in particular, CLP with T cell potential (LineageS
ca+cKit+IL7R+Thy1.2Ly6D; Inlay et al., 2009; Mansson et al., 
2010; Fig. 2, B and C), whereas B-lineage biased CLP (Line
ageSca+cKit+IL7R+Thy1.2Ly6D+; Tsapogas et al., 2011; 
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bone marrow T cell progenitors (Harman et al., 2005; Maeda 
et al., 2007). We assessed bone marrow CLP by flow cytome-
try for evidence of activated, or cleaved Notch and lower lev-
els were observed in OcnCre+/;iDTR mutants (Fig. 5 A). 
This was validated by a decrease in several Notch target genes 
by qPCR (Fig. 5 B). The five mammalian Notch ligands, Jag-
ged1, Jagged2, Delta-like 1 (DLL1), DLL3, and DLL4 were 
evaluated by qPCR and DLL4 was selectively decreased in 
bones from OcnCre+/;iDTR mutant mice (Fig. 5 C). Using 
a OsxCre-mCherry;OcnCre-Topaz double transgenic mouse 
model, we selectively labeled Osx+ cells red, Ocn+ cells green, 
Since Notch is an essential determinant of T-lymphoid 
commitment and is required for progression through the DN 
stage (Sambandam et al., 2005; Tan et al., 2005; Visan et al., 
2006; Rothenberg et al., 2010; Love and Bhandoola, 2011), 
we hypothesized that Notch may be participating in the phe-
notype observed. Notch participation in T-lymphopoiesis be-
fore thymic location was previously discounted (Krueger and 
von Boehmer, 2007), but the cells that were examined have 
since been shown to be precursors of extrathymic maturation 
and do not represent thymic progenitors (Luche et al., 2013). 
In contrast, some studies have reported Notch signaling in 
Figure 1. Ocn+ cell–specific deletion  
in vivo without altering osteoclastogenesis 
and mesenchymal progenitors. (A) WT mice 
(Ctrl) Ocn+ osteolineage cell deletion mice 
(Mut) were monitored for body size and 
weight; n = 8–10 mice/group. Data show 
mean ± SEM. (B) Femurs and tibiae in the 
OcnCre+/;iDTR mutants or WT (Ctrl) mice 
were assessed histologically. Bottom images 
are at a higher magnification with arrows 
pointing to empty lacunae within the cortex and 
altered endosteal surface; images reflect com-
parable findings in all animals; n = 8/experiment. 
(C) Osteoblasts in the OcnCre+/;iDTR and WT 
mice were quantitated by histomorphometry; 
n = 7–8 mice/group. Data show mean ± SEM. 
(D and E) Ocn and DTR expression was exam-
ined in bone sections from untreated  
OcnCre+/;iDTR by immunohistochemistry 
using Ocn- and DTR-specific antibodies (D),  
or by immunofluorescence using Ocn-specific 
antibodies and TUNEL staining after DT treat-
ment (E); n = 6 mice/group. (F) Osteoclast 
numbers were assessed by TRAP staining  
(n = 6 mice/group) and (G) osteoclast activity 
by collagen breakdown in sera using ELISA 
assay; n = 7–8 mice/group. Data show mean 
± SEM. (H) Mesenchymal progenitor activity 
in the bone marrow of OcnCre+/;iDTR mu-
tants or WT controls was assessed by CFU-Ob 
assay; n = 9 mice/group. Data show mean ± 
SEM. (I) CD31CD45Ter119LepR+ cells in 
the bone marrow stroma of OcnCre+/;iDTR 
mutants and controls were quantified by flow 
cytometry; n = 6–7 mice/group. Data show 
mean ± SEM. (A–I) For each experiment, 3–6 
independent repeats were performed.
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Figure 2. Ocn+ cell deletion decreases T cell competent lymphoid progenitors and T lineage cells. (A) Flow cytometric evaluation of lymphoid, 
myeloid, erythroid, and megakaryocytic mature cells and (B) T cell competent (Ly6D) CLP, B potential enriched (Ly6D+) CLP, CMP, GMP, and MEP popula-
tions in the bone marrow of control and Ocn+ cell–deleted animals. Minimum of three independent experiments; n = 8–16 mice/group. Data show mean ± 
SEM. (C) Gene set enrichment analysis (GSEA) comparing Ly6D CLP versus multipotent progenitor (MPP) microarray data. Experiment was performed 
twice independently; n = 3/experiment. (D) Flow cytometric quantification of different stages of B progenitors and mature cells in the bone marrow of 
OcnCre;iDTR mutant and control littermates. Experiment was performed twice independently; n = 5–6 mice/group. Data show mean ± SEM. (E) Flow cyto-
metric quantification of T cell subsets in the thymus. Minimum of four independent experiments; n = 8–12 mice/group. Data show mean ± SEM.
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We tested whether Notch ligand expression specifically 
by Ocn+ cells caused the lymphopoietic phenotype using the 
conditional OcnCreER;DLL4Fl/Fl strain. Ocn+ cell-specific 
DLL4 deletion resulted in significantly reduced Notch-activated 
CLP, T cell–competent Ly6D-CLP, and CCR7-expressing 
Ly6D-CLP (Fig. 6 A, discussed in the following paragraphs), 
with a decrease comparable in magnitude to that seen with 
Ocn+ cell depletion (Fig. 2 B). Thymic intermediates and 
blood T-lymphocytes were also decreased (Fig. 6 A).
Similar changes were noted when Mindbomb1 (Mib1) en-
coding an E3-ligase necessary for Notch ligand processing (Koo 
et al., 2005), was deleted in Ocn+ cells (Fig. 6 B). Together, 
these data demonstrate the role of Notch ligands expressed by 
Ocn+ cells as the basis for the decrease in T-lymphopoiesis.
and Osx+Ocn+ cells yellow. This system allowed clear distinc-
tion and isolation of different osteolineage subsets within 
the same animal by flow cytometry. Immunohistochemistry 
(Fig. 5 D) and gene expression data (Fig. 5 E) showed that Ocn+ 
mature osteoblasts, but not other osteolineage cells, potently 
expressed DLL4, and both mRNA and protein were markedly 
reduced in OcnCre+/;iDTR mice with protein notably de-
creased at the endosteal interface. This change in DLL4 was as-
sociated with corresponding alterations in Notch target genes 
in CLPs in the bone marrow by gene set enrichment analysis 
(GSEA; Fig. 5, F and G). These data suggest that reduced DLL4 
expression from Ocn+ cells led to reduced intracellular Notch 
activation in the hematopoietic precursors within the bone 
marrow, thereby limiting T-lineage specification.
Figure 3. Lymphopenic phenotype in OcnCre;iDTR mice was not caused by a stem cell defect. (A) 44,000 flow sorted Ly6D or Ly6D+ CLPs from 
SJL (CD45.1) mice were intravenously transplanted into each of 10 nonirradiated C57BL/6J (CD45.2) recipients. Recipients were bled 3 wk after transplant 
for enumeration of donor-derived B and T reconstitution by staining with CD45.1, B220, CD4 and CD8 antibodies and analysis by flow cytometry. Experi-
ment was performed twice independently; n = 10/experiment. Data show mean ± SEM. (B) Mature osteolineage cells were deleted from OcnCre;iDTR mice 
and hematopoietic stem cells (LKS SLAM), LineageLoc-Kit+Sca+ (LKS) multipotent progenitors, and LineageLoc-Kit+Sca cells were enumerated by flow cy-
tometry. (C) Cell cycle analysis of the indicated cell populations was performed by flow cytometry. (D) Frequency of apoptotic (AnnexinV+7-AAD) and 
necrotic (AnnexinV+7-AAD+) LKS SLAM, LKS, and LineageLoc-Kit+Sca cells was assessed. Experiments were repeated 3 times independently; n = 5–16 
mice/group. Data show mean ± SEM. (E) CD45.2 OcnCre;iDTR mutant or control donor cells were mixed with CD45.1 SJL donor cells in a 1:1 ratio, injected 
into primary SJL recipients. Reconstitution was assessed at 8, 12, and 16 wk after transplantation. Bone marrow cells from primary recipients were har-
vested and transplanted into secondary recipients. Reconstitution was assessed at 8, 12, and 16 wk following transplantation. Transplantation was per-
formed twice independently; n = 20–22 mice/experiment. Data show mean ± SEM.
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models confirm the role of Notch signaling in early T-lineage 
differentiation: altering bone marrow generation of thymic 
progenitors. Further, the comparable changes seen when ei-
ther the ligand or receptor were modified suggest that the 
interaction of Ocn+ cell and hematopoietic cells may be di-
rect rather than through other microenvironmental cell types 
and argue against the phenotype being on the basis of stress 
or secondary metabolic changes.
The abnormality in T-lymphopoiesis could reflect dys-
function of the thymus itself or of the immigrants to the thy-
mus arriving from the bone marrow. To assess this, we evaluated 
osteocalcin and DTR expression in thymic tissue, but found 
none by immunohistochemistry; no change in thymic his-
tology or thymic DLL4 mRNA by quantitative PCR was 
observed after Ocn+ cell depletion (unpublished data). To de-
termine if thymic function was altered in Ocn+ cell–deleted 
animals, we adoptively transferred WT Ly6D-CLP or 
LinSca+cKit+Flt3+ hematopoietic progenitor cells into the 
thymi of either OcnCre+/;iDTR mutant or control recipients 
in vivo, and detected no difference in thymocyte maturation. 
Testing of Notch-signaling in hematopoietic cells was 
then performed by several models. The Protein O-fucosyl-
transferase1 gene product (Pofut1) transfers O-fucose to the 
EGF-like repeats on Notch and is required for the binding of 
Delta-like ligands (Yao et al., 2011). Deleting it using Mx1-
Cre+/;Pofut1Fl/Fl mice revealed decreased CLP and Ly6D-
CLP compared with controls (Fig. 7 A). Because Pofut1 
does not act exclusively on Notch receptors, the down-
stream signaling mediator RBP-J was also assessed. Mx1-
Cre deletion of RBP-J compromised bone marrow CLP 
and Ly6D-CLP (Fig. 7 B). Further, intrafemoral injection 
of the -secretase inhibitor N-[N-(3,5-difluorophenacetyl)- 
l-alanyl]-S-phenylglycine t-butyl ester (DAPT) reduced CLP 
and Ly6D-CLP on the ipsilateral side (Fig. 8 A). Lastly, 
intravenously transplanted 106 Lin hematopoietic progeni-
tor cells from Mx1Cre;LSL-NICD-GFP mice expressing 
a dominant-active Notch intracellular domain (NICD) res-
cued the OcnCre;iDTR lymphoid defect in Ly6D-CLP 
and Ly6DCCR7+-CLP compared with Mx1Cre;LSL-GFP 
controls (Fig. 8 B). Collectively, these in vivo genetic mouse 
Figure 4. Ocn+ cell regulation of T lymphopoiesis is dependent on bone marrow microenvironment. (A) 106 WT CD45.1 hematopoietic bone mar-
row cells were transplanted into lethally irradiated CD45.1 OcnCre;iDTR hosts that were untreated or treated with DT. Animals were bled at 8, 12, and 
16 wk after transplantation for blood count and assessment of hematopoietic reconstitution by flow cytometry. (B) 5 × 105 bone marrow cells from ei-
ther control or mutant CD45.2 OcnCre+/;iDTR donors were mixed with 5 × 105 CD45.1 SJL bone marrow competitors in a 1:1 ratio and transplanted into 
lethally irradiated WT SJL recipients. Animals were bled at 8, 12, and 16 wk after transplantation for blood count and hematopoietic reconstitution by 
flow cytometry. (A and B) Two independent transplantations were performed; n = 20–22 mice/experiment. Data show mean ± SEM. (C) Cell cycle status, 
apoptosis, and necrosis in CLPs in OcnCre+/;iDTR mutants and controls were assessed by flow cytometry. 2 independent experiments; n = 5–6 mice/
group. Data show mean ± SEM.
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the Ocn+ cell–depleted bone marrow (Fig. 9 A). The reversal 
of abnormalities in all T-intermediate stages in the thymus 
also led to fully restored mature CD4+ and CD8+ populations 
in the bone marrow (Fig. 9 A). Similar results were observed 
using LinSca+Kit+Flt3+ cells. No extrathymic development 
was observed in organs, including bone marrow, spleen, 
lymph node, and intestine. Therefore, the perturbation of 
T cell development induced by Ocn+ cell depletion appears 
to be in enabling bone marrow thymus-seeding cell forma-
tion and migration, not in impaired differentiation capacity 
of cells once they arrive in the thymus.
These data argue against an altered thymic microenvironment 
(or metabolic milieu) induced by the deletion of Ocn+ cells 
or DT administration as the basis for altered T cell differentia-
tion. They also argue against, but cannot definitively exclude, 
secondary effects of stress on the lymphopoietic phenotype.
Examining whether the thymocyte production defects 
were cell autonomous, we adoptively transferred 3 × 104 
Ly6D-CLPs cells from bone marrow of control or Ocn+ 
cell depleted animals intrathymically into WT mice. After 
3 wk, no evidence for a defect in the thymocyte maturation 
sequence was observed for cells derived from the context of 
Figure 5. Reduced DLL4 in the bone 
marrow of Ocn+ cell depleted mice led  
to decreased Notch signaling in CLP.  
(A) Intracellular Notch signaling was assessed 
by flow cytometry in the indicated cell popu-
lations. Representative flow plots are shown, 
and data are summarized by dot plot (right). 
Three independent experiments; n = 16–17 
mice/group. Data show mean ± SEM.  
(B) Expression of the indicated Notch target 
genes in Ly6D CLP from OcnCre+/;iDTR 
mutants and controls. Mutant and WT mice 
were treated with DT for 28 d before being 
subjected to flow cytometry for Ly6D CLP 
isolation and quantitative PCR. Two inde-
pendent experiments; n = 12 mice/group. 
Data show mean ± SEM. (C) Expression of the 
Notch ligands in the bones of OcnCre+/;iDTR 
DT-treated and control animals was assessed 
by qPCR. Mice were examined after 28 d after 
DT treatment. Three independent experiments; 
n = 12–14 mice/group. Data show mean ± 
SEM. (D) DLL4 expression in bone sections 
from control or Ocn+ cell deleted animals was 
assessed by immunohistochemistry. Two inde-
pendent experiments; n = 6 mice/group.  
(E) Osx-mCherry cells and Ocn-Topaz 
cells were isolated from the OsxCre-
mCherry;OcnCre-Topaz double transgenic 
mice by flow cytometry and expression of 
the indicated Notch ligands was assessed by 
qPCR. Experiment performed twice; n = 3/
experiment. Data show mean ± SEM. (F) Gene 
set enrichment analysis (GSEA) comparing 
Ly6D CLP versus MPP microarray data. Ex-
periment performed twice; n = 3/experiment. 
(G) GSEA comparing Ly6D CLP microarray 
data obtained from OcnCre;iDTR control ver-
sus mutant mice. Experiment was performed 
twice independently; n = 3–4/experiment.
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CCR7+CLP and PSGL1+CLP (Fig. 9 B). CCR7+CLP was 
also decreased in OcnCreER+/;DLL4/, OcnCreER+/; 
Mib1/, Mx1Cre+/;Pofut1/, Mx1Cre+/;RBPjk/ mice, 
and -secretase injected femurs compared with littermate 
controls (Figs. 6–8). Together, these data indicate that Ocn+ 
cell depletion results in decreased thymic-seeding progenitors 
and in decreased production of the thymic homing molecule, 
CCR7, in those progenitors.
Because Notch has been reported to mediate the expres-
sion of chemokine receptors in T cell leukemia (Mirandola 
et al., 2012), we assessed whether OcnCre+/;iDTR bone 
marrow cells properly express the chemokine receptors 
(Krueger et al., 2010) or ligands (Sultana et al., 2012) necessary 
for thymic seeding. We observed modestly decreased CCR7 
expression intensity in the CLPs without changes in CCR9 
or PSGL1, but with a significant decrease in the number of 
Figure 6. Conditional deletion of DLL4 or Notch ligands in Ocn+ cells impaired T lymphopoiesis. (A) OcnCreER+/;Dll4Fl/Fl mutants and 
OcnCreER+/;Dll4+/+ control littermates were injected with 2mg 4-OH-tamoxifen/15 g BW eight times over 4 wk to induce deletion of the DLL4 ligand. 
Mice were harvested immediately after 4 wk of deletion and bone marrow CLPs, thymic T cell progenitors, and peripheral blood mature T cells were enu-
merated by flow cytometry. Experiment was performed 3 times independently; n = 9–10 mice/group. Data show mean ± SEM. (B) OcnCreER+/;Mib1Fl/Fl 
mutants and OcnCreER+/;Mib1+/+ control littermates were injected with 2 mg 4-OH-tamoxifen/15 g BW 8 times over 4 wk to induce deletion of the Mib1 
gene. Mice were harvested immediately after 4 wk of deletion and bone marrow CLPs, thymic T cell progenitors, and peripheral blood mature T cells were 
enumerated by flow cytometry. Experiment was performed twice independently; n = 6–8 mice/group. Data show mean ± SEM.
JEM Vol. 212, No. 5
Article
767
tag were used as positive controls for homing defective 
cells and similarly competed in a 1:1 ratio into recipi-
ents. Recipient thymi were evaluated 24 h after transplant. 
OcnCre+/;iDTR mutant or CCR7/ donor cells were 
similarly compromised in thymic homing ability compared 
with controls (Fig. 9 C). These data suggest that the reduc-
tion in thymocytes may be due to failure to generate thymic-
homing competent cells in the bone marrow of Ocn+ cell 
To test whether thymus migratory capacity of bone mar-
row cells was reduced in vivo, we conducted competitive 
homing experiments. LKS Flt3+ cells (1.5 × 104) or CLPs 
(two doses: 3.5 × 104 or 104) from control or Ocn+ cell-depleted 
mice were isolated, stained with distinctive fluorescent tags, 
and intravenously injected at a 1:1 ratio into SJL recipients 
(Fig. 9 C). In parallel, equivalent cells sorted from age 
matched CCR7/ mice labeled with a distinctive fluorescent 
Figure 7. Conditional ablation of Notch signaling in hematopoietic cells impaired T lymphopoiesis. (A) Mx1Cre+/;Pofut1Fl/Fl mutants and 
Mx1Cre+/;Pofut+/+ control littermates were injected with 12.5 µg/g BW polyinosinic:polycytidylic acid (poly(I:C)) every alternate day for 7 d to induce 
deletion of the Pofut1 gene. Mice were harvested 4 wk after injection and bone marrow CLPs, thymic T cell progenitors, and peripheral blood mature  
T cells were enumerated by flow cytometry. Experiment was performed twice independently; n = 4–6 mice/group. Data show mean ± SEM. (B) Mx1Cre+/;RBPjkFl/Fl 
mutants and Mx1Cre+/;RBPjk+/+ control littermates were injected with 12.5 µg/g BW poly(I:C) every alternate day for 7 d to induce deletion of RBP-J. 
Mice were harvested 4 wk after injection and bone marrow CLPs, thymic T cell progenitors, and peripheral blood mature T cells were enumerated by flow 
cytometry. Experiment was performed twice independently; n = 6–8 mice/group. Data show mean ± SEM.
768 Dll4 specifies thymus-seeding progenitors | Yu et al.
(Androutsellis-Theotokis et al., 2006; Benedito et al., 2012; 
Moya et al., 2012). Control and mutant OcnCre+/;iDTR 
mice were treated with daily DT injections from day 19. 
At day 5, mutant OcnCre+/;iDTR mice were co-injected 
with either 100 ng/g BW or 1 µg/g BW of DLL4 intrave-
nously. All mice were harvested at day 0. Results showed 
that injection of a high concentration of DLL4 into the 
bloodstream rescued the OcnCre+/;iDTR bone marrow 
CLP and increased CCR7 expression on CLPs (Fig. 10 A) 
deleted animals. The defect in homing capacity may be 
caused by decreased CCR7 or PSGL1 or the combination of 
the two in the absence of Ocn+ cells in the bone marrow.
To test our hypothesis that Ocn+ cells instruct early 
T-lineage specification in bone marrow through DLL4, 
we injected the Ocn+ cell–depleted animals with recombi-
nant mouse DLL4. Although this ligand is generally cell 
associated, it has been shown by others to induce Notch 
activation when administered as a recombinant protein 
Figure 8. Notch blockade in the bone marrow by -secretase inhibitor impaired thymic T cell development, whereas Notch overexpression res-
cued T lymphoid defect. (A) 2.5 mM DAPT or PBS was injected into the left femur of each of 8 C57BL/6J mice at day 12, 9, 6. At day 0, the left femur, 
thymus, and peripheral blood were harvested for enumeration of bone marrow CLPs, thymic T cell progenitors, and peripheral blood mature T cells by flow 
cytometry. Experiment was performed twice independently; n = 4–8 mice/group. Data show mean ± SEM. (B) 106 Lineage-depleted hematopoietic progeni-
tors were flow sorted from poly(I:C)-induced Mx1Cre;LSL-NICD-GFP mice or Mx1Cre;LSL-GFP control mice and transplanted into either OcnCre;iDTR mutant 
or control recipients. Recipients were harvested 1 wk after transplant and bone marrow CLPs, thymic T cell intermediates, and mature peripheral blood T cells 
were analyzed by flow cytometry. Experiment was performed twice independently; n = 8 mice/group. Data show mean ± SEM.
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Figure 9. Ocn+ cell–depleted animals had intact thymic function but impaired CLP homing ability. (A) 30,000 flow sorted bone marrow CLPs 
from diphtheria treated OcnCre+/;iDTR animals (Mut) or controls (Ctrl) were injected into the thymus of either OcnCre+/;iDTR DT treated (Mut) or con-
trol (Ctrl) animals. Injection of PBS served as mock controls. Thymic T progenitor and mature populations were assessed after 4 wk. Two independent 
experiments; n = 4–6 mice/group. Data show mean ± SEM. (B) CCR7, CCR9, and PSGL1 cell surface expression on CLP from Ocn+ cell–depleted or control 
mice was assessed by flow cytometry. Panels on the left show expression levels (indicated by fluorescent intensity on the y axis) and dot plots on the 
right show numbers of cells with positive expression. Minimum two independent experiments; n = 8–10 mice/group. Data show mean ± SEM. (C) CLPs 
from diphtheria-treated OcnCre;iDTR control and mutant mice were labeled with green and red fluorescent dyes, respectively, mixed in a 1:1 ratio and 
transplanted intravenously into congenic SJL recipients, and harvested 24 h after transplant. Equal number of CLPs harvested from CCR7/ mice was 
used as another control and competed with OcnCre;iDTR mutant CLPs in a similar manner. Donor-derived cells were enumerated from recipient thymi  
24 h after transplant. Experiment was repeated with reciprocal dye to control for dye labeling efficiency. 2 independent experiments; n = 10 mice/
experiment. Data show mean ± SEM.
and subsequent thymic T cell development (Fig. 10, B–K), 
resulting in normalized mature T number in the bone mar-
row (Fig. 10 L). Supplement of a low concentration of DLL4 
only partially increased bone marrow CLP (Fig. 10 A), but 
restored all subsequent stages of T development downstream 
in the thymus (Fig. 10, B–K). These data are consistent with 
770 Dll4 specifies thymus-seeding progenitors | Yu et al.
a particularly immunosuppressive clinical scenario and one 
where T cell reconstitution is markedly delayed. We also noted 
that granulocyte colony-stimulating factor (G-CSF), com-
monly used after transplantation, adversely affected Ocn+ cells 
as did -interferon, a cytokine associated with immune activa-
tion with infection or GvHD (Fig. 10 M). These data suggest 
that the context of allogeneic hematopoietic stem cell trans-
plantation may adversely affect critical components of the 
niche for full immunological reconstitution.
These studies indicate that Ocn+ bone cells may enable 
T-lineage competent cell production and thymus seeding 
through expression of DLL4. Although DLL4 is well defined 
as necessary to enforce T-lineage differentiation in the thymus 
and cells of multipotency are present in the thymus (Hozumi 
et al., 2008; Koch et al., 2008; Mohtashami et al., 2010), the data 
here suggest a contribution of bone cells and bone marrow to 
DLL4 acting at the level of both the bone marrow and thy-
mus. The impact of DLL4 was both in cell number and 
CCR7 expression in the bone marrow consistent with a role 
in both processes.
DISCUSSION
Immune reconstitution after allogeneic hematopoietic stem 
cell transplantation is a major clinical problem resulting in sig-
nificant patient morbidity and mortality. We tested whether the 
number of Ocn+ cells might be compromised in vivo under 
settings related to hematopoietic stem cell transplantation. We 
generated mice that simultaneously label Osx-expressing cells 
and Ocn-expressing cells with distinct fluorescence markers 
and enumerated the cells by flow cytometry. A specific and 
marked reduction of Ocn+ cells was observed in a model of al-
logeneic transplantation and graft-versus-host disease (GvHD), 
Figure 10. In vivo rescue of T lineage defect by intravenous infusion of DLL4. (A–L) OcnCre;iDTR control and mutant mice were first treated with 
DT for 21 d to induce Ocn+ cell deletion, then injected with recombinant DLL4 intravenously at two different dosages: 100 ng/g BW or 1 µg/g BW. Flow 
cytometric evaluation of effects on the number of bone marrow CLPs (A), thymic T cell intermediates (B–K), and mature T cells circulated back to the bone 
marrow (L). Experiments was performed twice independently; n = 6–12 mice/group. Data show mean ± SEM. (M) Transgenic mice with osteolineage cells 
at the progenitor stage (Osx+) labeled red, intermediate stage (Osx+Ocn+) labeled yellow, and mature stage (Ocn+) labeled green were treated with either 
saline control (CNTR), parathyroid hormone (PTH), granulocyte colony-stimulating factor (G-CSF), IFN-, LPS, or transplanted in a noncompatible setting 
to elicit graft-versus-host disease (GvHD). The number of Osx+, Osx+Ocn+, and Ocn+ cells in femurs were enumerated by FACS. Experiment was performed 
twice; n = 8 mice/experiment. Results are means ± SEM.
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and procedures performed were approved by the Institutional Animal Care 
and Use Committee of Massachusetts General Hospital.
Bone histology. Tibiae were fixed in 70% ethanol and embedded without 
demineralization in methyl methacrylate for histomorphometric analysis. 
5-µm sections were stained with toluidine blue to quantify static parameters, 
including bone volume per tissue volume, trabecular number, trabecular sep-
aration, osteoblast and osteocyte number per tissue area, and osteoclast num-
ber per bone perimeter. Unstained sections were used to measure dynamic 
parameters, including bone formation rate per tissue volume. A sampling site 
with an area of 1.4 mm2 was established in the secondary spongiosa of the 
metaphysis at 450 µm below the growth plate. A standard histomorphometric 
analysis was performed using the OsteoMeasure system (Osteometrics, Inc.) 
and the results were expressed according to standardized nomenclature 
(Parfitt et al., 1987). Statistical analysis was achieved using the nonparametric 
Mann-Whitney test (n = 7–8). For paraffin sections, femurs and tibiae were 
collected and fixed in 4% paraformaldehyde overnight, decalcified by 20% 
EDTA for 1 wk, washed in PBS, dehydrated through a series of alcohol 
changes up to 70% EtOH, and embedded in paraffin. Paraffin sections were 
stained with hematoxylin and eosin for general morphology, as well as von 
Kossa and Goldner trichrome. Tartrate-resistant acid phosphatase (TRAP) 
staining was used to reveal osteoclasts. Alteration of osteoblastic activity was 
assessed by measuring serum levels of osteocalcin and N-terminal propeptide 
of type I procollagen (P1NP) using RatLaps ELISA kits (n = 22–24). Changes 
in osteoclastic bone resorption was assessed by measuring the C-terminal 
telopeptides of collagen type I fragments in mouse serum using RatLaps EIA 
kit (n = 22–24).
Immunohistochemistry. Expression of the DT receptor on cell surface 
was detected by immunohistochemical staining of paraffin sections with 
anti–human heparin-binding EGF-like growth factor (anti–hHB-EGF) anti-
body (R&D Systems; AF-259-NA). In brief, deparaffinized and rehydrated 
sections were treated with 0.1% trypsin for antigen unmasking and 3% H2O2 
to block endogenous peroxidase activity. Sections were then blocked with 
reagent containing 5% animal serum in PBS-T for 1 h. Goat polyclonal 
anti–hHB-EGF antibody was used at 1:25 dilution, coupled with horse bio-
tinylated anti–goat IgG secondary antibody (Vector Lab) at 1:400 dilution. 
Rabbit polyclonal anti-DLL4 antibody (Abcam; ab84081) was used at a 1:50 
dilution, coupled with biotinylated anti–rabbit antibody at 1:250 dilution 
(Vector Lab). After antibody staining, sections were washed in PBS-T, 
treated with VECTASTAIN ABC kit for biotin-streptavidin signal amplifi-
cation, and subsequently visualized by DAB Peroxidase Substrate kit. 
Phycoerythrin-conjugated anti-PECAM1 antibody (BD) was applied at 
1:100 dilution and mounted with DAPI containing mounting medium. Ocn 
expressing mature osteoblasts and osteocytes were recognized by goat poly-
clonal anti-osteocalcin antibody (Santa Cruz Biotechnology, Inc.; sc-18322) 
at 1:50 dilution followed by donkey anti–goat IgG secondary antibody con-
jugated to Alexa Fluor 488 at 1:1,000 dilution. Green fluorescent osteocal-
cin-antibody stainings were individually superimposed with red fluorescent 
TUNEL (In situ Cell Death Detection kit TMR Red; Roche) staining.
Colony forming unit–osteoblast (CFU-Ob) assay. Bone marrow cells 
were collected from each mouse by flushing end-excised femurs and tibiae 
with PBS containing penicillin and streptomycin. Collected bone marrow 
cells were incubated with ACK lysis buffer to remove red blood cells, washed 
with PBS, and plated at 107 cells per well in a 6-well plate supplemented 
with DMEM and 10% FBS. Nonadherent cells were removed on the fifth 
day and adherent cells were replated at 5 × 106 cells per well and cultured in 
the same media until confluent. Once cultures reached confluency, medium 
was changed into DMEM containing 50 µg/ml ascorbic acid, 108 M dexa-
methasone, and 8 mM -glycerophosphate and changed every 2–3 d to in-
duce osteogenic differentiation. 14 d later, cultures were fixed in 4% PFA, 
and stained with 0.5% Alizarin Red for visualization of mineralized nodules 
with brightfield microscopy. Cells were plated in triplicates and assay was 
repeated three times.
robust T-lymphopoiesis in young adult animals. Other studies 
of modifying bone cell CCL12 production or deletion of 
DMP-1+ cells have indicated, respectively defects in CLP (but 
not mature T cells) or of thymus, T cells, and B cells and 
metabolism broadly (Ding and Morrison, 2013; Greenbaum 
et al., 2013; Sato et al., 2013). The lack of T cell phenotype 
in our OsxCre+/;iDTR model was unexpected and there 
could be several explanations. Differences in Cre deletion 
efficiency could be one reason, as we achieved 50% cell 
deletion in the OsxCre+/;iDTR model compared with 70% 
deletion in the OcnCre+/;iDTR system. Second, the relative 
balance of Osx+ cells versus Ocn+ cells in the bone marrow 
may be important for creating a B versus T-progenitor niche. 
Systemic or indirect effects imposed by Osx+ or Ocn+ cell 
deletion also remains possible. Based on our current data, 
we present a model where a specific Notch-ligand, produced 
by a specific subset of bone cells drive T-lineage competence 
and enable thymus-seeding cell production. This model 
may inform strategies to improve T-lineage production and 
reconstitution in settings of disease, particularly because the 
bone cells involved appear to be susceptible to loss in con-
texts like transplantation where T cell generation is of great 
clinical consequence.
MATERIALS AND METHODS
Mouse models. All single transgenic mouse strains were maintained in a 
C57BL/6J background by backcrossing to C57BL/6J for at least 10 back-
crosses. To specifically delete mature osteolineage cells, the OC-cre strain 
(from T.L. Clemens, Johns Hopkins University, MD; Zhang et al., 2002), 
which expressed Cre under the Osteocalcin promoter was crossed to the iDTR 
strain (Buch et al., 2005). Temporally controlled cell ablation was achieved 
upon injection of DT into the OcnCre+/;iDTR strain. Similarly, Osx+ cell 
deletion was achieved by crossing the Osx1-GFP::Cre mouse (Rodda and 
McMahon, 2006) to the iDTR strain. To study the effect of Ocn+ cells on 
hematopoiesis, OcnCre+/ injected with DT or OcnCre+/;iDTR injected 
with PBS served as controls while OcnCre+/;iDTR injected with DT were 
used as mutants. For osteoprogenitor deletion, control mice were OsxCre+/ 
injected with DT or OsxCre+/;iDTR injected with PBS, whereas 
OsxCre+/;iDTR injected with DT served as mutants. For most experi-
ments, 25 ng DT in PBS/g of body weight was injected daily into both con-
trol and mutant animals for 28 d from 4 wk of age to achieve an acute 
deletion of specific osteolineage populations. Mice were harvested for analy-
sis the next day after the last dose of diphtheria injection. Notch ligand inac-
tivation in Ocn+ cells was achieved by crossing the Ocn-CreER strain 
(Park et al., 2012) with Dll4lox/lox strain (K. Hozumi, Tokai University, 
Kanagawa, Japan; Hozumi et al., 2008) and with Mib1F/F strain (Koo et al., 
2005; OcnCreER;DLL4Fl/Fl and OcnCreER;Mib1Fl/Fl). Mouse models of 
Notch inactivation in hematopoietic cells was achieved by crossing the 
B6.Cg-Tg(Mx1-Cre)1Cgn/J (Mx1-Cre; The Jackson Laboratory) strain 
with Pofut1F/F (Y.-Y. Kong, Seoul National University, Seoul, Republic of 
Korea; Shi and Stanley, 2003) and RBP-Jf/f (T. Honjo, Kyoto University, 
Kyoto, Japan; Han et al., 2002) strains (Mx1Cre;Pofut1Fl/Fl and 
Mx1Cre;RBPjkFl/Fl). Mouse strains Gt(ROSA)26Sortm1(Notch1)Dam/J 
(LSL-NICD-GFP), B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J (LSL-
GFP), and C57BL/6-Tg(BGLAP-Topaz)1Rowe/J (OcnCre-Topaz) were 
obtained from The Jackson Laboratory. OsxCre-mCherry;OcnCre-Topaz 
was generated by crossing Osx-CreER (Park et al., 2012), Rosa-LSL-mCherry 
(The Jackson Laboratory), and OcnCre-Topaz strains. For all experiments, 
littermates were used as controls. C57BL/6J and B6.SJL-PtprcaPepcb/BoyJ 
(SJL) strains were obtained from The Jackson Laboratory. All animal usage 
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process of SPIATM DNA/RNA primer hybridization, DNA replication, 
strand displacement and RNA cleavage which resulted in a rapid accumula-
tion of cDNA with sequence complementary to the original RNA. The 
SPIATM amplified cDNA was purified using the Zymo Research DNA 
Clean & Concentrator system. The purified cDNA was fragmented through 
a chemical and enzymatic process and labeled via enzymatic attachment of 
a biotin-labeled nucleotide to the 3-hydroxyl end of the fragmented cDNA. 
The biotinylated cDNA was added to a hybridization solution containing 
several biotinylated control oligonucleotides (for quality control), and hy-
bridized to the Mouse430A microarray chip overnight at 45°C. The chips 
were then transferred to a fluidics instrument that performs washes to remove 
cDNA that has not hybridized to its complementary oligonucleotide probe. The 
bound cDNA was then fluorescently labeled using phycoerythrin-conjugated 
streptavidin (SAPE); additional fluors were then added using biotinylated 
anti-streptavidin antibody and additional SAPE. Each cDNA bound at its 
complementary oligonucleotide was excited using a confocal laser scanner, 
and the positions and intensities of the fluorescent emissions were captured. 
These measures provide the basis of subsequent biostatistical analysis. Stan-
dard QA/QC analyses involved chip analysis with the assay QualityMetrics 
BioConductor package and found no significant quality issues with any of 
the chips, as determined by (among other methods) visual inspection, in-
tensity distributions, or RNA degradation plots. The data were background 
corrected and normalized with RMA (Robust Multichip Average) using the 
“affy” BioConductor package. Values in the data matrix represent log2 nor-
malized intensity values.
All microarray datasets have been deposited in NCBI’s Gene Expression 
Omnibus (GEO) and are accessible through GEO Series accession nos. 
GSE66042 and GSE66102.
Quantitative PCR. Flow sorted cells were extracted for RNA using the 
RNAqueous-4PCR kit (Ambion). Flushed and crushed femoral bones of 
mutant or control animals were used for RNA extraction by TRIzol. Quan-
titative PCR were performed with TaqMan probes using the expression of 
the housekeeping GAPDH gene for normalization.
Competitive thymic homing experiment. 35,000 or 10,000 Ly6D- CLPs 
(LinSca+cKit+IL7R+Thy1.2Ly6D) were sorted from OcnCre;iDTR 
control and mutant donors (CD45.2-Pacific Blue), labeled with 10 µM 
CFDA-SE (Invitrogen) and 1 µg/ml VivoTag680 (VT680, VisEn Medical), 
respectively, mixed in a 1:1 ratio, and transplanted into each congenic SJL 
recipient (CD45.1-PE) by retro-orbital injection. The same number of pro-
genitor cells sorted from CCR7/ mice served as another control to com-
pete with OcnCre;iDTR mutant donors. Recipient thymi were harvested 
24 h after transplant and donor-derived cells (CD45.2-Pacific Blue) from 
OcnCre;DTR control (CFDA-SE) and mutant (VT680) were enumerated 
by flow cytometry. To account for differential dye-labeling efficiency, the 
experiment was repeated with the competing cells stained with reciprocal 
dyes, mixed in equal ratio, and transplanted into SJL mice in the same man-
ner. Experiment was also performed using 15,000 sorted LinSca+cKit+Flt3+ 
hematopoietic progenitors as donor cells.
Intrathymic adoptive transfer assay. We follow the procedure described 
previously (Goldschneider et al., 1986) with the following modifications: 
Mice were anesthetized with intraperitoneal injection of a mixture of ket-
amine (100 mg/kg) and xylazine (10 mg/kg). Sorted Ly6D-CLP (LinSca+c
Kit+IL7R+Thy1.2Ly6D) or Flt3+ LKS (LinSca+cKit+Flt3+) cells (30,000 
cells in 20 µl PBS) were injected at two sites in the anterior superior portion 
of each thymus lobe (10 µl/site) using a Hamilton syringe mounted with a 
30-gauge needle. After surgical procedure, mice were placed under the heat 
lamp for 30 min to aid recovery from anesthesia and were monitored daily 
for any signs of discomfort after the Pain Assessment Protocol published by 
the National Research Council (US) Committee. Mice that demonstrated 
signs of persistent pain were euthanized. Mice were sacrificed on the 14th 
day after surgery by CO2 asphyxiation and cervical dislocation, and thymi 
were harvested for cell analysis by flow cytometry.
Flow cytometry. Before sacrifice, peripheral blood was collected from each 
mouse and subjected to complete blood cell count. For each mouse, tibiae, 
femurs, iliac crests, spines, ulnae, radii, and humeri were collected for bone 
marrow cells. In addition, spleen and thymus were also collected for lympho-
cyte staining. Changes in hematopoietic populations were quantified by flow 
cytometry. Bone marrow cells harvested from each animal were counted. We 
routinely stained 5 × 107 cells per sample for the hematopoietic stem popula-
tion, and 107 cells per sample for each progenitor and mature population. Lin-
eage cocktail consists of biotinylated B220, CD3e, CD4, CD8a, CD19, 
CD11b, Gr1, Ter119, CD11c, and NK1.1 antibodies. Fluorescence conju-
gated to streptavidin was used to recognize lineage cocktail. The following 
antibody combinations were used to recognize different hematopoietic popu-
lations: hematopoietic stem and progenitor cells (Lineage-Pacific Orange, 
Sca-Pacific Blue, cKit-APC-Cy7, CD48-APC, CD150-PE-Cy7), CLP 
(Lineage-Pacific Orange, Sca-Pacific Blue, cKit-APC-Cy7, CD127-PE-Cy7, 
Thy1.2-FITC, Ly6D-APC), GMP, CMP and MEP (Lineage-Pacific Orange, 
Sca-Pacific Blue, cKit-APC-Cy7, CD34-FITC, CD16/32-PE-Cy7), B cells 
(B220-APC), mature T cells (CD4-Pacific Blue, CD8-APC), monocytes 
(CD11b-APC), granulocytes (Gr1-FITC), erythroid cells (CD45-APC, 
Ter119-PE), megakaryocytes (CD41-APC). For thymic T cell development, 
we used: CD25-FITC, CD44-PE, cKit-APC-Cy7, CD4-Pacific Blue, CD8-
APC. Ki67-FITC and DAPI staining were coupled with staining of any spe-
cific populations to reveal cell cycle status, while Annexin V and 7-AAD 
staining were used for apoptotic analysis.
Transplantation. For transplantation of WT hematopoietic cells into Ocn+ 
cell depleted mutant environment, 1 × 106 bone marrow mononuclear cells 
from 6-wk-old SJL donors were transplanted into each of 10 age-matched 
9.5 Gy lethally irradiated OcnCre+/ control or OcnCre+/;iDTR mutant 
recipients. DT administration into both control and mutant recipients began 
at 4 wk before transplantation and were maintained every alternate day until 
16 wk after transplantation. Recipients were bled at 8, 12, 16 wk after trans-
plantation. Peripheral blood was subjected to complete blood cell count and 
stained for CD45.1-PE, CD45.2-APC to measure donor reconstitution by 
flow cytometry. At 16 wk after transplantation, all recipients were sacrificed. 
Bone marrow cells were harvested from femurs, tibiae, iliac crests, and red 
blood cell, and then lysed and stained with CD45.1-PE, CD45.2-APC, 
Mac1-APC, Gr1-FITC, B220-APC, CD4-APC, and CD8-FITC antibodies 
to measure reconstitution by individual lineages using flow cytometry.
To competitively transplant bone marrow hematopoietic cells from 
OcnCre+/;iDTR animals into WT recipients, 5 × 105 bone marrow mono-
nuclear cells from 6-wk-old mutant OcnCre+/;iDTR or control OcnCre+/ 
donors were competed with 5 × 105 bone marrow mononuclear cells from 
age-matched congenic SJL donors. For both control and donor group, a total 
of 106 mixed donor cells were transplanted into each of 10 age-matched 9.5 Gy 
irradiated SJL recipients. Recipients were bled at 8, 12, and 16 wk after trans-
plantation. Peripheral blood was subjected to complete blood cell count and 
stained with CD45.1-PE, CD45.2-APC antibodies for donor reconstitution 
readout by flow cytometry. At 16 wk after transplantation, all recipients were 
sacrificed. Red blood cells were lysed and total bone marrow cells were 
stained with CD45.1-PE, CD45.2-APC, Mac1-APC, Gr1-FITC, B220-APC, 
CD4-APC, and CD8-FITC antibodies to measure lineage reconstitution by 
flow cytometry.
Microarrays. Osx+, Osx+Ocn+, and Ocn+ cells were sorted at 6 d after 
tamoxifen injection from 4–6-wk-old OsxCre-mCherry;OcnCre-Topaz 
mice using FACSAria (BD). Ly6D CLPs were sorted from 6–8 wk old 
OcnCre;iDTR mutants and controls using the FACSAria after daily DT 
treatment for 4 wk. RNA was extracted using TRIzol (Invitrogen) according 
to the manufacturer’s instructions. Samples were processed by the NuGen 
Ovation V2 laboratory process in the microarray core facility of the Dana 
Farber Cancer Institute. In brief, first stand cDNA was prepared from total 
RNA using a DNA/RNA chimeric primer and a reverse transcription. The 
resulting double stranded cDNA with a unique heteroduplex at the 5 end 
of the antisense strand were amplified using SPIATM amplification, a repeated 
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DLL4 rescue experiment. Control OcnCre+/ and mutant OcnCre+/;iDTR 
mice were intraperitoneally injected with 100 ng/g BW DT daily since day 
19. Starting from day 5, OcnCre;DTR mutants were co-injected daily 
with either 100 ng/g BW or 1 µg/g BW of recombinant mouse DLL4 
(R&D Systems) intravenously. All mice were harvested at day 0 for bone 
marrow cells and thymi collection. Bone marrow cells were red blood cell 
lysed and stained for CLP, CD4, and CD8-specific antibodies, whereas 
thymocytes were stained for T developmental specific antibodies for flow 
cytometric analysis. The experiment was repeated twice.
Intratibial injection of DAPT. We injected 10 µl of either 2.5 mM DAPT 
(EMD Millipore) or PBS as control into the left tibia of each of eight 
C57BL/6 mice at day 12, 9, and 6, and harvested the left femur, thy-
mus, and peripheral blood at day 0 for flow cytometric analysis.
GvHD model. For the induction of GvHD, 5 × 106 bone marrow cells 
were mixed with 2 × 106 CD4/CD8+ purified splenic T cells from BALB/c 
donor mice and injected in Osx-Cre;Rosa-fl-STOP-fl-mCherry;Ocn-GFP 
triple transgenic recipient mice that had been previously irradiated with 
9.5 Gy. Control recipient mice received 5 × 106 bone marrow cells mixed 
with 2 × 106 CD4/CD8+ splenic T cells from C57BL/6 donor mice. The 
purification of the CD4/8+ T cells was achieved using the MACS LD cell 
separation columns and the MACS Streptavidin MicroBeads (Miltenyi 
Biotec). Mice were monitored for signs of GvHD daily and the degree of 
clinical GvHD was assessed weekly by a scoring system that sums changes in 
five clinical parameters: weight loss, posture (hunching), activity, fur texture 
and skin integrity. 2 wk after the transplantation, mice were sacrificed.
Statistical analysis. Statistical analysis of all paired experiments was ana-
lyzed by two-tailed Student’s t test. All graphs were represented with mean 
and standard error of the mean, where *, P < 0.05; **, P < 0.01; ***, P < 
0.001; and ****, P < 0.0001, unless otherwise stated. Statistical comparison 
of multiple parameters were analyzed by One-way ANOVA, followed 
by Bonferroni post-test, where *, P < 0.05; **, P < 0.01; ***, P < 0.001; 
and ****, P < 0.0001.
Online supplemental material. Fig. S1 shows flow gating strategies for 
bone marrow singlets and B cells. Fig. S2 depicts flow gating strategies for 
bone marrow T cells, monocytes, granulocytes, erythroid cells, and mega-
karyocytes. Fig. S3 illustrates flow gating strategies for bone marrow hema-
topoietic progenitor cells. Fig. S4 diagrams flow gating strategies for intrathymic 
T cells. Fig. S5 describes flow gating strategies for LepR+ cells in the bone 
marrow stroma. Online supplemental material is available at http://www 
.jem.org/cgi/content/full/jem.20141843/DC1.
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